Hypertension is one of the main factors causing cardiovascular diseases. The aim of the study is to investigate the effects of Chlorella pyrenoidosa on blood pressure and cardiorenal remodeling in rats with N ω-nitro-l-arginine methyl ester hydrochloride (L-NAME)-induced endothelial dysfunction.
Rats were fed a diet containing L-NAME (40 mg/kg) with or without chlorella (4 or 8 %) for 5 weeks. We found that chlorella retarded the development of hypertension and cardiorenal remodeling during the 5-week experimental period.
Although there was no difference in NO x levels or plasma arginine concentrations, plasma and tissues ACE activities were significantly lower in the chlorella groups than in the L-NAME group. Moreover, tissue tumor necrosis factor-α concentrations and renal CYP4A expression were also lower in the chlorella group.
These results suggest that chlorella might ameliorate the elevation of blood pressure and show cardiorenal-protective effects in nitric oxide-deficient rats, and one possible mechanism might be mediated by its ACE inhibitory activity.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Taddei S, Virdis A, Mattei P et al (1996) Defective l-arginine-nitric oxide pathway in offspring of essential hypertensive patients. Circulation 94:1298–1303
Ribeiro MO, Antunes E, de Nucci G, Lovisolo SM, Zatz R (1992) Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension 20:298–303
Ceconi C, Fox KM, Remme WJ et al (2007) ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT. Cardiovasc Res 73:237–246
Miranda MS, Sato S, Mancini-Filho J (2001) Antioxidant activity of the microalga Chlorella vulgaris cultered on special conditions. Boll Chim Farm 140:165–168
Sansawa H, Takahashi M, Tsuchikura S, Endo H (2006) Effect of chlorella and its fractions on blood pressure, cerebral stroke lesions, and life-span in stroke-prone spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo) 52:457–466
Merchant RE, Andre CA, Sica DA (2002) Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 5:141–152
Griesmacher A, Kindhauser M, Andert SE et al (1995) Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469–475
Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71
Shalaby SM, Zakora M, Otte J (2006) Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J Dairy Res 73:178–186
Palm F, Nordquist L (2011) Renal oxidative stress, oxygenation, and hypertension. Am J Physiol Regul Integr Comp Physiol 301:R1229–R1241
Sugamura K, Keaney JF Jr (2011) Reactive oxygen species in cardiovascular disease. Free Radic Biol Med 51:978–992
Vijayavel K, Anbuselvam C, Balasubramanian MP (2007) Antioxidant effect of the marine algae Chlorella vulgaris against naphthalene-induced oxidative stress in the albino rats. Mol Cell Biochem 303:39–44
Lee HS, Choi CY, Cho C, Song Y (2003) Attenuating effect of chlorella supplementation on oxidative stress and NFkappaB activation in peritoneal macrophages and liver of C57BL/6 mice fed on an atherogenic diet. Biosci Biotechnol Biochem 67:2083–2090
Pechanova O, Simko F (2009) Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind. J Hypertens 27(Suppl 6):S32–S36
Napoli C, Sica V, de Nigris F et al (2004) Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J 148:e5
Kitamoto S, Egashira K, Kataoka C et al (2000) Chronic inhibition of nitric oxide synthesis in rats increases aortic superoxide anion production via the action of angiotensin II. J Hypertens 18:1795–1800
Siani A, Pagano E, Iacone R et al (2000) Blood pressure and metabolic changes during dietary l-arginine supplementation in humans. Am J Hypertens 13:547–551
Mann GE, Yudilevich DL, Sobrevia L (2003) Regulation of amino acid and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 83:183–252
Ast J, Jablecka A, Bogdanski P et al (2010) Evaluation of the antihypertensive effect of l-arginine supplementation in patients with mild hypertension assessed with ambulatory blood pressure monitoring. Med Sci Monit 16:CR266–CR271
De Gennaro Colonna V, Rigamonti A, Fioretti S et al (2005) Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats. Eur J Pharmacol 516:253–259
Pereira LM, Almeida JR, Mandarim-de-Lacerda CA (2004) Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats. Life Sci 74:1375–1386
Vijan SG (2009) Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. J Indian Med Assoc 107:178–182
Suetsuna K, Chen JR (2001) Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol (NY) 3:305–309
Katoh M, Egashira K, Mitsui T et al (2000) Angiotensin-converting enzyme inhibitor prevents plasminogen activator inhibitor-1 expression in a rat model with cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis. J Mol Cell Cardiol 32:73–83
Zhang H, Park Y, Wu J et al (2009) Role of TNF-alpha in vascular dysfunction. Clin Sci (Lond) 116:219–230
Gonzalez W, Fontaine V, Pueyo ME et al (2000) Molecular plasticity of vascular wall during N(G)-nitro-l-arginine methyl ester-induced hypertension: modulation of proinflammatory signals. Hypertension 36:103–109
Fogari R, Zoppi A (2005) Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant? Am J Cardiovasc Drugs 5:211–223
Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC (1999) Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest 104:1131–1137
Huang H, Zhou Y, Raju VT et al (2005) Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats. Am J Physiol Renal Physiol 289:F1116–F1122
All the authors have seen and approved the contents of the submitted manuscript. All the authors stated that there are no conflicts of interest, and all the authors adhere to the Committee on Publication Ethics guidelines on research and publication ethics. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors. The contribution of each author was as follows: Yi-Ching Yang, Hsiang-Chi Peng, Pei-Yin Ho: doing experiments; Su-Ching Yang, Hsin-Yi Yang: writing of the manuscript and designing the study.
Conflict of interest
All authors have no relevant conflict of interest to disclose.
About this article
Cite this article
Yang, SC., Yang, HY., Yang, YC. et al. Chlorella pyrenoidosa ameliorated L-NAME-induced hypertension and cardiorenal remodeling in rats. Eur J Nutr 52, 601–608 (2013). https://doi.org/10.1007/s00394-012-0362-0